Literature DB >> 21375436

Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.

Clive Ballard, Anne Corbett, Samantha Sharp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21375436     DOI： 10.1586/ern.11.13

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  5 in total

Review 1.  Drug repositioning for Alzheimer's disease.

Authors:  Anne Corbett; James Pickett; Alistair Burns; Jonathan Corcoran; Stephen B Dunnett; Paul Edison; Jim J Hagan; Clive Holmes; Emma Jones; Cornelius Katona; Ian Kearns; Patrick Kehoe; Amrit Mudher; Anthony Passmore; Nicola Shepherd; Frank Walsh; Clive Ballard
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

Review 2.  Repurposing Licensed Drugs for Use Against Alzheimer's Disease.

Authors:  Leslie C Norins
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Drug repositioning: an opportunity to develop novel treatments for Alzheimer's disease.

Authors:  Anne Corbett; Gareth Williams; Clive Ballard
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-11

4.  Drug utilization pattern in patients with different types of dementia in Western India.

Authors:  Mansi Patel; Anuradha Joshi; Jalpa Suthar; Soaham Desai
Journal:  Int J Alzheimers Dis       Date:  2014-08-27

Review 5.  A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery.

Authors:  Thanigaimalai Pillaiyar; Sangeetha Meenakshisundaram; Manoj Manickam; Murugesan Sankaranarayanan
Journal:  Eur J Med Chem       Date:  2020-04-02       Impact factor: 6.514
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.